16 results for author:"Aigner A." in Literature citations
Results Customize
› Repeat search in UniProtKB (6)
| RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo. Hendruschk S., Wiedemuth R., Aigner A., Topfer K., Cartellieri M., Martin D., Kirsch M., Ikonomidou C., Schackert G., Temme A. Neuro-oncology 13:1074-1089(2011) · Mapped (9) |
| The proto-oncogene Pim-1 is a target of miR-33a. Thomas M., Lange-Grunweller K., Weirauch U., Gutsch D., Aigner A., Grunweller A., Hartmann R.K. Oncogene 31:918-928(2012) · Mapped (3) |
| CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Ripka S., Neesse A., Riedel J., Bug E., Aigner A., Poulsom R., Fulda S., Neoptolemos J., Greenhalf W., Barth P. et al. Gut 59:1101-1110(2010) · Mapped (5) |
| Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo. Grzelinski M., Pinkenburg O., Buch T., Gold M., Stohr S., Kalwa H., Gudermann T., Aigner A. Clin. Cancer Res. 16:1402-1415(2010) · Mapped (9) |
| HMGA2 gene is a promising target for ovarian cancer silencing therapy. Malek A., Bakhidze E., Noske A., Sers C., Aigner A., Schafer R., Tchernitsa O. Int. J. Cancer 123:348-356(2008) · Mapped (2) |
| The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. von Haussen J., Koczulla R., Shaykhiev R., Herr C., Pinkenburg O., Reimer D., Wiewrodt R., Biesterfeld S., Aigner A., Czubayko F. et al. Lung Cancer 59:12-23(2008) · Mapped (2) |
| The fibroblast growth factor-binding protein FGF-BP. Abuharbeid S., Czubayko F., Aigner A. Int. J. Biochem. Cell Biol. 38:1463-1468(2006) · Mapped (1) |
| Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma. Grzelinski M., Bader N., Czubayko F., Aigner A. Int. J. Cancer 117:942-951(2005) · Mapped (1) |
| Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. Ulbricht U., Brockmann M.A., Aigner A., Eckerich C., Muller S., Fillbrandt R., Westphal M., Lamszus K. J. Neuropathol. Exp. Neurol. 62:1265-1275(2003) · Mapped (1) |
| Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. Roelle S., Grosse R., Aigner A., Krell H.W., Czubayko F., Gudermann T. J. Biol. Chem. 278:47307-47318(2003) · Mapped (12) |
| Immunolocalization of an FGF-binding protein reveals a widespread expression pattern during different stages of mouse embryo development. Aigner A., Ray P.E., Czubayko F., Wellstein A. Histochem. Cell Biol. 117:1-11(2002) · UniProtKB (1) · Mapped (5) |
| Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. Powers C., Aigner A., Stoica G.E., McDonnell K., Wellstein A. J. Biol. Chem. 277:14153-14158(2002) · UniProtKB (1) · Mapped (18) |
| Enhancement of fibroblast growth factor (FGF) activity by an FGF-binding protein. Tassi E., Al-Attar A., Aigner A., Swift M.R., McDonnell K., Karavanov A., Wellstein A. J. Biol. Chem. 276:40247-40253(2001) · UniProtKB (2) |
| Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C., Caughey D.J., Wen D., Karavanov A., Riegel A.T. et al. J. Biol. Chem. 276:16772-16779(2001) · UniProtKB (2) |
| Tissue distribution and retinoid-mediated downregulation of an FGF-binding protein (FGF-BP) in the rat. Aigner A., Malerczyk C., Houghtling R., Wellstein A. |
| A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Czubayko F., Liaudet-Coopman E.D., Aigner A., Tuveson A.T., Berchem G.J., Wellstein A. Nat. Med. 3:1137-1140(1997) · UniProtKB (1) |